1. Introduction
===============

About 75% of an individual's general information is obtained through the visual system ([@b1-epj-09-5516]). The visual system of children does not take its final evolution up to the age of 10 years and the most important factor for growth and development of this system is clear stimuli ([@b2-epj-09-5516]). If the child's eye is deprived of receiving these stimuli, for any reason, the development of the visual system will be impaired ([@b3-epj-09-5516]). Visual acuity is of great importance in children for clear vision in writing and education, especially in school training ages ([@b1-epj-09-5516]). Visual disorders have dramatic effects on health, self-esteem, and educational function of students and if diagnosed with delay, it will cause complications, like academic failure and mental difficulties for the student ([@b4-epj-09-5516]). Also, delay in diagnosis of visual difficulties can decrease the treatment success ([@b5-epj-09-5516]). Most visual disorders are preventable at an early age. Therefore, a comprehensive study of visual problems in students is of great importance. According to studies, the most common cause of visual disorders in children include refractive errors (1--11%), amblyopia (1--5%) and strabismus (3.8%) ([@b6-epj-09-5516]). Unfortunately, there is no comprehensive statistical information available in Iran and only sparse data have been reported from cities in national scientific sources ([@b7-epj-09-5516]). Considering the importance of research about visual problems in children and differences in the prevalence of visual disorders in different parts of Iran, the present systematic review and meta-analysis aimed to determine the prevalence of common visual disorders in Iranian students.

2. Material and Methods
=======================

The present systematic review and meta-analysis study was carried out in 2015, and articles published since 1996 to 2014, related to the prevalence of visual disorders in Iranian children, in Farsi and English were searched in national and foreign databases, including SID, Magiran, IranDoc, IranMedex, MedLib, PubMed, ISI, and Google Scholar. Mentioned databases were searched using the following keywords in Persian and English: disorders, vision, amblyopia, refractive errors, astigmatism, student, and Iran with all the possible combinations, important, chief, and sensitive words. Also, the titles resulted through search and references of the selected articles were used as additional search tools. All descriptive cross-sectional or group studies that had investigated the prevalence of visual disorders in Iran were considered. Articles were selected based on three steps of title, abstract and full text. Studies with insufficient information or non-descriptive cross-sectional studies, congress abstracts, studies published in other languages than English and Persian, review and meta-analysis studies, and duplicates were excluded from the analysis. For all studies, the following data were extracted: the first author, publication year, study year, study location, sample size, and mean age, sex and the prevalence of each visual disorder ([Table 1](#t1-epj-09-5516){ref-type="table"}). The major inclusion criteria for including various articles into this study was mentioning visual disorders and exclusion criteria of the studies from the present research were: lack of reference to the prevalence of visual disorders, unrelated studies, and low quality of articles. The researcher collected all articles related to visual disorders first and prepared a list of abstracts after finishing the search. In this step, 86 articles were listed, which mentioned "The prevalence of visual disorders in Iran". Then, each article was independently evaluated. In this step, 14 articles were eliminated because of duplication, and among a total of 72 articles, 16 articles were omitted because of low quality, and 4 because of the unavailability of the full text, and 24 articles were deleted due to differences in the types of criteria. Finally, 28 articles were appropriate to enter meta-analysis ([Figure 1](#f1-epj-09-5516){ref-type="fig"}). A checklist of necessary information was prepared for all studies primarily evaluated. Then, a checklist containing several parts was designed, including researcher's name, publication year and place, sample size, age, visual disorders, prevalence of visual disorders, etc. Then, fundamental data needed for research entered the chart for analysis. For calculation of variance of each study, binary distribution and for combination of prevalence of visual disorders among various studies, mean weight was used. Each study was weighed proportional to the reverse of its variance. With attention to the great difference in the prevalence among different studies (heterogeneity of studies) and significance of Heterogeneity index (I2), Random Effects Model was used in the meta-analysis. And finally, the data was analyzed by R Software and STATA (Version 11.2). The level of significance (P value) was considered less than 5%.

3. Results
==========

Basic information of studies that entered meta-analysis, including the author's name, year of publication, study place, the sample size, based on gender and age range are shown in [Table 1](#t1-epj-09-5516){ref-type="table"}. The total number of subjects was 1,117,274, in the age range of 2 to18 years old. The raw data on prevalence of ocular disorders in different studies are demonstrated in [Table 2](#t2-epj-09-5516){ref-type="table"}. In [Figure 2](#f2-epj-09-5516){ref-type="fig"}, the prevalence of strabismus in Iranian students is shown based on the random effects model. In this graph, the resultant prevalence of strabismus was 1% (CI 95%: 1--2%). In [Figure 3](#f3-epj-09-5516){ref-type="fig"}, the total prevalence of refractive errors in Iranian students is shown based on the random effects model. It has been shown that the prevalence of refractive errors was an estimated 7% (CI 95%: 5--9%). Moreover, the prevalence of amblyopia in Iranian students was 8% based on random effects model ([Figure 3](#f3-epj-09-5516){ref-type="fig"}) (CI 95%: 7--10%). The overall prevalence of visual disorders has been shown in [Table 3](#t3-epj-09-5516){ref-type="table"}. Based on the results of this study, the overall prevalence of visual disorders in Iranian students was 5% ([Table 3](#t3-epj-09-5516){ref-type="table"}), in which the prevalence of amblyopia was 8% \[Girl 2% (CI 95%: 1--3%), boy 1% (95% confidence interval: 1--2%)\], refractive error was 7% \[Girl 8% (CI 95%: 6--10%), boy 6% (95% confidence interval: 4--7%)\], and the prevalence of strabismus was an estimated 1% ([Table 3](#t3-epj-09-5516){ref-type="table"}). The prevalence of amblyopia in Iranian students, based on random-effects model was shown in the [Figure 4](#f4-epj-09-5516){ref-type="fig"}. The greatest amount of astigmatism-related refractive error was 19% \[girls 27% (CI 95%: 6--61%) and boys 28% (CI 95%: 5--51%)\], followed by myopia with a prevalence of 17% ([Table 3](#t3-epj-09-5516){ref-type="table"}). Details of the prevalence of refractive errors are shown in [Table 3](#t3-epj-09-5516){ref-type="table"}.

4. Discussion
=============

One of the goals of the WHO (world health organization) is to prevent visual disorders in children by the year 2020 ([@b31-epj-09-5516]). According to studies, visual disorders, especially refractive errors, strabismus and amblyopia are higher in students than in other groups ([@b34-epj-09-5516]--[@b36-epj-09-5516]). Amblyopia occurs in the first decade of life and if diagnosed at this age, it can be treated, and prevention of further development can be done by appropriate treatment measures ([@b32-epj-09-5516], [@b33-epj-09-5516]). In the present study, the prevalence of amblyopia among Iranian students was 8%, while based on similar studies in developed countries, the prevalence of amblyopia in preschool children has been reported as 1--5% ([@b48-epj-09-5516]--[@b50-epj-09-5516]). The overall prevalence of visual disorders, including amblyopia, strabismus, refractive errors and other ocular diseases in children, was 2.4--6.1% in various articles ([@b51-epj-09-5516]). In the present study, the prevalence of visual disorders in students was 5%, which was higher compared with many developed countries ([@b37-epj-09-5516]--[@b41-epj-09-5516]). Of course, differences in the various reports could be due to taking into account the different diagnostic criteria, different characteristics of the study population, and skills and expertise of the examiners ([@b2-epj-09-5516], [@b52-epj-09-5516]--[@b60-epj-09-5516]). In the present study, the prevalence of strabismus was 1%, which is consistent with the findings of previous studies, however differences in the prevalence of different types of strabismus (phoria or tropia, exo, or eso) are likely, but given that in most of the selected studies, the type of strabismus was not specified, it was not possible to compare the prevalence of different types. The overall prevalence of strabismus in studies conducted in different parts vary from 0.5 to 2% ([@b2-epj-09-5516], [@b16-epj-09-5516], [@b17-epj-09-5516]). Another common cause of visual disorders among this age group was refractive errors, which was 7% in the present study. Numerous studies are conducted worldwide in the field of refractive errors in the age groups at risk, including children and students, and prevalence of these disorders are highly variable in different regions ([@b17-epj-09-5516]--[@b24-epj-09-5516], [@b26-epj-09-5516]--[@b29-epj-09-5516]). According to most studies conducted in the world, myopia is introduced as the most common refractive error among students ([@b63-epj-09-5516], [@b64-epj-09-5516]). Also, in some comprehensive studies out of Iran, the prevalence of myopia has been reported higher than hyperopia ([@b65-epj-09-5516]). This difference in the prevalence needs to be confirmed by further studies.

5. Conclusions
==============

Various reports have questioned screening for visual disorders in Iran, and on the basis of these studies ([@b64-epj-09-5516], [@b65-epj-09-5516]), these programs are not sensitive enough to detect and refer patients to seek appropriate treatment, on the other hand, given that most parents rely on the results of these examinations, and do not pay attention to the possible complaints of their children, identification of these disorders are delayed and their treatment becomes more difficult ([@b43-epj-09-5516], [@b44-epj-09-5516]). Therefore, it is suggested to increase the awareness of parents, use highly-experienced staff in screening programs, and increase the validity and sensitivity of the examinations by more professional methods.
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###### 

General information of studies included in the meta-analysis

  Ref. no.             Publication year   Study year   Age of cases (year)   Male (n)   Female (n)   n (total)   City
  -------------------- ------------------ ------------ --------------------- ---------- ------------ ----------- --------------
  [@b9-epj-09-5516]    2014               2013         3--6                                          1,126       Bojnoord
  [@b6-epj-09-5516]    2006               2000         7--12                 2,348      2,185        4,533       Kermanshah
  [@b11-epj-09-5516]   2009               2005--2006   14--18                216                     216         Tehran
  [@b12-epj-09-5516]   2004               1999--2000   3--6                                          8,427       Ardebil
  [@b28-epj-09-5516]   2008               2006                               1,208      942          2,510       Mashhad
  [@b13-epj-09-5516]   2010               2004         11--17                3,635      913          4,548       Ardebil
  [@b14-epj-09-5516]   2007               2004         6                     436        379          815         Shahrood
  [@b8-epj-09-5516]    2009               2007         7--18                                         957,582     Iran
  [@b2-epj-09-5516]    1999               1996         7                                             2,000       Shahrekord
  [@b3-epj-09-5516]    2014               2011--2012   2--6                  8,297      8,302        16,599      Bandar Abbas
  [@b15-epj-09-5516]   2016               2012         2--6                  1,160                   75,173      Ardebil
  [@b16-epj-09-5516]   2012               2011         7--15                                         1,551       Bojnourd
  [@b17-epj-09-5516]                      2010         14--18                                        1,133       Varamin
  [@b18-epj-09-5516]   2014                                                  5,641      6,180        11,821      Qazvin
  [@b19-epj-09-5516]   2010               2008         \<15                  1,191      1,941        3,132       Mashhad
  [@b20-epj-09-5516]   2015               2012         7--12                                         320         Zahedan
  [@b21-epj-09-5516]   2013               2010         7--14                 643        898          1,551       Bojnourd
  [@b22-epj-09-5516]   2016               2013                               2,127                   4,106       Iran
  [@b23-epj-09-5516]   1996                            7--8                  951        775          1,726       Kerman
  [@b24-epj-09-5516]   2007                            12--16                                        1,830       Mashhad
  [@b25-epj-09-5516]   1997               1996         7--12                                         1,275       Zanjan
  [@b26-epj-09-5516]   2007               2004--2005   7--15                                         3,673       Dezful
  [@b26-epj-09-5516]   2007               2004--2005   14--18                                        1,871       Dezful
  [@b27-epj-09-5516]   2014                            14--21                212        222          434         Aligoudarz
  [@b28-epj-09-5516]   2008               2006--2007   7--15                                         1,163       Mashhad
  [@b28-epj-09-5516]   2008               2006--2007   14--18                                        947         Mashhad
  [@b29-epj-09-5516]   2015               2013--2014   6--15                 631        520          1,151       Dezful
  [@b30-epj-09-5516]   2010               2008--2009   7--15                 1,002      870          1,872       Shiraz

###### 

Prevalence of ocular disorders in studies included in the meta-analysis

  Ref. no.             Astigmat. Prev.   Estrab. Prev.   Ref. Eror Prev.   Amb. prev.   Total prev.   Anisometropia   Hyperopia Prev.   Myopia Prev.   Astigmat. Prev. Boys   Astigmat. Prev. female   Refractive Eror Prev. male   Refractive Eror Prev. female   Amblyopia prev. male   Amblyopia prev. female
  -------------------- ----------------- --------------- ----------------- ------------ ------------- --------------- ----------------- -------------- ---------------------- ------------------------ ---------------------------- ------------------------------ ---------------------- ------------------------
  [@b9-epj-09-5516]                      1.8             4.61              11.8                                                                                                                        2.66                         1.9                            6.21                   5.59
  [@b6-epj-09-5516]    1.78                              5                 0.33         5.7                           0.61              2.6            1                      0.8                                                                                  0.21                   0.45
  [@b11-epj-09-5516]   21.3              17.1                                                                                                                                                                                                                                             
  [@b12-epj-09-5516]                     0.55            3.59              1.25         7.21                                                                                                                                                                                              
  [@b28-epj-09-5516]   11                3.1                               1.9                        30.6                                                                                                                                                         1.7                    2.1
  [@b13-epj-09-5516]   27                0.9             11.4              2.63         2.63          59              17                                                                                                                                           2.8                    1.9
  [@b14-epj-09-5516]                                                                    6.4                                                                                                                                                                                               
  [@b8-epj-09-5516]                                                                     4.6                                                                                                                                                                                               
  [@b2-epj-09-5516]                      0.55                              9.9          2.55          1.5                                                                                                                                                          12.5                   14.8
  [@b3-epj-09-5516]                      0.27            2.72              1.01                                                                                                                                                                                                           
  [@b15-epj-09-5516]                     0.34            0.074             0.14                                                                                                                                                                                    0.17                   0.12
  [@b16-epj-09-5516]                     2                                 2.3                                                                                                                                                                                     2                      2.5
  [@b17-epj-09-5516]   10.5              1.5                               2.1                        3.8             6.1               33.2                                                                                                                                              
  [@b18-epj-09-5516]   8.37                                                6.34                       5.45            19.8              66.2           48.48                  51.52                                                                                44.73                  55.27
  [@b19-epj-09-5516]   15.34                                                                          5.84                                                                                                                                                                                
  [@b20-epj-09-5516]   3.4                                                                            21.3            5.8               6.3            1.8                    5                        55.6                         73.1                                                  
  [@b21-epj-09-5516]   22                                6.2                                                          18                40                                                             4.8                          7.1                                                   
  [@b22-epj-09-5516]   17.43                                                                                          6.2               3.04           15.46                  19.54                                                                                                       
  [@b23-epj-09-5516]                                     7.5               1.7                                                                                                                         6.2                          9.4                            1.4                    2
  [@b24-epj-09-5516]   5.02                              24.97                                                        4.97              3.77                                                                                                                                              
  [@b25-epj-09-5516]   2.03              0.47            8.4               7.8                        1.33            2.1               3.5                                                                                                                                               
  [@b26-epj-09-5516]   18.7                                                                                           16.6              3.4            18.5                   18.9                                                                                                        
  [@b26-epj-09-5516]   18                                                                                             2.1               33             18.5                   18.9                                                                                                        
  [@b27-epj-09-5516]   20.7                                                                           4.6             1.2               29.3           25.9                   15.8                                                                                                        
  [@b28-epj-09-5516]   9.8                                                                            3               87.9              2.4                                                                                                                                               
  [@b28-epj-09-5516]   11.8                                                                           5.6             8.4               24.1                                                                                                                                              
  [@b29-epj-09-5516]   45.3                                                                                           12.9              14.9           48.5                   41.5                                                                                                        

###### 

The prevalence of visual disorders in Iranian students; derived from meta-analysis study

  Visual disorder (Prevalence %)   I^2^%   p-value   Prevalence (CI 95%)   Studies number
  -------------------------------- ------- --------- --------------------- ----------------
  Myopia                           99.9    0.000     0.17 (0.09--0.25)     16
  Hyperopia                        99.9    0.000     0.16 (0.10--0.22)     17
  Anisometropia                    99.8    0.000     0.11 (0.06--0.17)     13
  Amblyopia                        99.8    0.000     0.08 (0.07--0.10)     14
  strabismus                       97.2    0.000     0.01 (0.01--0.02)     12
  Astigmatism                      99.9    0.000     0.19 (0.06--0.32)     20
